Correction to: Cellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM-CSF and IL-18 can induce significant antitumor effects

Abstract

Following publication of the original article [1], the authors reported an error in Fig 5 of this article, graphs presenting FCM and immunofluorescent for CD4T, CD8T and NK cell of the Control Groups (LL2, LL2-irradation, MCS-irradiation) were inadvertently duplicated from another parallel experiment.

Fig. 5

Increased proliferation of CD4 ⁺ INF-γ ⁺ T, CD8 ⁺ INF-γ ⁺ T in spleen and infiltration of CD4 ⁺ T, CD8 ⁺ T in tumors. Spleen lymphocytes were isolated and stained for CD4, CD8 and INF-γ double staining antibodies by flow cytometry; Tumor tissue was obtained 3 days after the last measurement of tumor volume, frozen sections were used for analysis of CD4, CD8 T and NK cell infiltration. a The proportion of CD4⁺INF-γ⁺ T, CD8⁺ INF-γ⁺ T in co-expression IL-18 and GM-CSF-treated mice was significantly higher than control groups (P < 0.01, n = 7). Experiments were performed in triplicate and repeated three times. b Immunofluorescence staining of tumor tissue with CD4, CD8 and NK antibody showed that CD4⁺, CD8⁺ T cell infiltrations was significant enhanced in co-expression IL-18 and GM-CSF-treated group as compared with control groups (P < 0.01, n = 7) (original magnification, ×200)